Evaluating the impact of age on immune checkpoint therapy biomarkers
Cell Rep
.
2021 Nov 16;37(7):110033.
doi: 10.1016/j.celrep.2021.110033.
Authors
Rossin Erbe
,
Zheyu Wang
,
Sharon Wu
,
Joanne Xiu
,
Neeha Zaidi
,
Jennifer La
,
David Tuck
,
Nathanael Fillmore
,
Nicolas A Giraldo
,
Michael Topper
,
Stephen Baylin
,
Marc Lippman
,
Claudine Isaacs
,
Reva Basho
,
Ilya Serebriiskii
,
Heinz-Josef Lenz
,
Igor Astsaturov
,
John Marshall
,
Josephine Taverna
,
Jerry Lee
,
Elizabeth M Jaffee
,
Evanthia T Roussos Torres
,
Ashani Weeraratna
,
Hariharan Easwaran
,
Elana J Fertig
PMID:
34788629
DOI:
10.1016/j.celrep.2021.110033
No abstract available
Publication types
Published Erratum
Grants and funding
P50 CA062924/CA/NCI NIH HHS/United States
R01 CA230995/CA/NCI NIH HHS/United States
U01 AG066101/AG/NIA NIH HHS/United States